Stock listing
NASDAQ:OXFD Oxford Immunotec Global PLC Stock
Follow Oxford Immunotec Global PLC into a list and get an email when it puts out news.
Last close · NASDAQ:OXFD
$21.99 USD
Close on Mar 10, 2021 · No longer trades
- Lowest – highest close
- $7.90 – $24.42 USDSince Nov 21, 2013 · lowest Jul 25, 2016 · highest Mar 7, 2014
Delisted NASDAQ:OXFD no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:OXFD
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Oxford Immunotec Global PLC on 6ix
- Decks
- 3 decks · latest Jan 7, 2019
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (January 2019) | Investor deck | 19 slides | Jan 7, 2019 |
| Merger or Acquisition (September 2018) | Merger or acquisition | 9 slides | Sep 25, 2018 |
| Investor Presentation (January 2018) | Investor deck | 21 slides | Jan 8, 2018 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| James R. Tobin Other companies: Lyra Therapeutics, Inc. (Lead Independent Director · Since at least Mar 4, 2022); TransMedics Group, Inc. (Director · Since at least May 1, 2019); Globus Medical, Inc. (Director · Since at least Aug 28, 2015); Corindus Vascular Robotics Inc (Director · Mar 13, 2018 – Oct 29, 2019 · Past); Chiasma Inc (Director · Nov 23, 2015 – Jun 9, 2016 · Past); Boston Scientific Corporation (President & CEO, Director · Feb 7, 2008 – Feb 24, 2009 · Past); Curis, Inc. (Director · Jun 1, 2006 – Jan 26, 2015 · Past); Applied Biosystems Inc. (Director · Mar 1, 2006 – Nov 21, 2008 · Past) | Director · Dec 1, 2014 – Mar 8, 2021 · Past |
| Herm Rosenman Other companies: Natera, Inc. (Director · Since at least Sep 14, 2018); VIVUS Inc (Director · Feb 20, 2020 – Feb 20, 2020 · Past); Constellation Alpha Capital Corp (Director · Aug 29, 2019 – Jun 1, 2023 · Past) | Director · Jun 18, 2019 – Mar 8, 2021 · Past |
| Richard Sandberg Other companies: Precipio, Inc. (Chairman of the Board · Since at least Dec 3, 2019); Ethan Allen Interiors Inc. (Director · Jul 25, 2006 – Jul 24, 2009 · Past); North American Scientific Inc (Director · May 3, 2006 – Apr 29, 2008 · Past) | Director · Nov 21, 2013 – Mar 8, 2021 · Past |
| Ronald Andrews Other companies: Plus Therapeutics, Inc. (Director · Since at least Mar 20, 2026); Precipio, Inc. (Director · Since at least Mar 1, 2021); Insight Molecular Diagnostics Inc. (Former CEO, Director · Jul 1, 2019 – Dec 1, 2022 · Past) | Director · Jun 18, 2019 – Mar 8, 2021 · Past |
| Patrick Balthrop Other companies: MaxCyte, Inc. (Non-Executive Director · Since at least Nov 30, 2022); Personalis, Inc. (Director · Jun 19, 2019 – May 15, 2020 · Past) | Director · Jan 29, 2016 – Mar 8, 2021 · Past |
| Elizabeth M Keiley Other companies: Entasis Therapeutics Holdings Inc (General Counsel · Apr 28, 2019 – Jul 7, 2022 · Past) | SVP & General Counsel · Jan 1, 2015 – Mar 4, 2019 · Past |
| Richard Wenstrup Other companies: Myriad Genetics, Inc. (Chief Medical Officer · Jul 1, 2015 – Sep 30, 2016 · Past) | Chief Medical Officer · Jul 24, 2017 – Mar 15, 2018 · Past |
| Stefan C Linn Other companies: IMS Health Holdings Inc (See Remarks · Apr 3, 2014 – Feb 10, 2015 · Past) | Chief Operating Officer · Aug 28, 2017 – Mar 11, 2020 · Past |
| Stephen L Spotts Other companies: Genoptix Inc (Director · Oct 29, 2007 – Oct 29, 2007 · Past) | Director · Nov 21, 2013 – Jun 6, 2017 · Past |
| Andrew Scott Walton | Director · Nov 4, 2015 – Mar 8, 2021 · Past |
All 19 people
| Person | Seat |
|---|---|
| Janet Louise Kidd | General Counsel · Nov 18, 2019 – Mar 8, 2021 · Past |
| Jeff R Schroeder | Chief Commercial Officer · Nov 21, 2013 – May 8, 2017 · Past |
| Mark R Klausner | Director · Mar 1, 2018 – Mar 8, 2021 · Past |
| Matthew T E McLaughlin | Chief Financial Officer · Apr 8, 2019 – Mar 8, 2021 · Past |
| Nigel A Pitchford | Director · Nov 21, 2013 – Nov 21, 2013 · Past |
| Patricia Randall | Director · Nov 21, 2013 – Mar 8, 2021 · Past |
| Peter Edwardson | Chief Operations Officer · Nov 21, 2013 – Aug 15, 2017 · Past |
| Peter Wrighton-Smith | Chief Executive Officer, Director · Nov 21, 2013 – Mar 8, 2021 · Past |
| Richard M Altieri | Chief Financial Officer · Nov 21, 2013 – Jan 1, 2019 · Past |
Log in to ask 6ix AI your own questions about Oxford Immunotec Global PLC.